Clinical Trials
7
Active:0
Completed:5
Trial Phases
1 Phases
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (100.0%)Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine
Not Applicable
Withdrawn
- Conditions
- Migraine
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT05804396
The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)
Not Applicable
Completed
- Conditions
- MDD
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 126
- Registration Number
- NCT04279522
- Locations
- 🇺🇸
Kadima Neuropsychiatry Institute, La Jolla, California, United States
🇺🇸UCLA Semel Institute for Neuroscience and Behaviour, Los Angeles, California, United States
🇺🇸San Marcus Research Clinic, Miami Lakes, Florida, United States
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Not Applicable
Completed
- Conditions
- Acute Migraine
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 187
- Registration Number
- NCT03631550
- Locations
- 🇺🇸
Clinical Research Consortium, an AMR company, Las Vegas, Nevada, United States
🇺🇸Hartford HealthCare Headache Center, Hartford, Connecticut, United States
🇺🇸Yale School of Medicine, New Haven, Connecticut, United States
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Not Applicable
Completed
- Conditions
- Migraine
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT03398668
- Locations
- 🇮🇱
Laniado Medcial Center, Netanya, Israel
A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.
Not Applicable
Terminated
- Conditions
- Migraine
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT03185559
- Locations
- 🇮🇱
Meir General Hospital, Kfar Saba, Israel
- Prev
- 1
- 2
- Next
News
No news found